PA
Perceptive Advisors’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-706,567
| Closed | -$26.7M | – | 99 |
|
|
2025
Q1 | $26.7M | Sell |
706,567
-1,011,850
| -59% | -$38.2M | 0.94% | 30 |
|
|
2024
Q4 | $141M | Sell |
1,718,417
-309,191
| -15% | -$25.3M | 3.88% | 7 |
|
|
2024
Q3 | $232M | Buy |
2,027,608
+165,000
| +9% | +$18.9M | 4.9% | 5 |
|
|
2024
Q2 | $141M | Sell |
1,862,608
-70,151
| -4% | -$5.3M | 3.39% | 7 |
|
|
2024
Q1 | $132M | Buy |
1,932,759
+844,273
| +78% | +$57.7M | 2.31% | 10 |
|
|
2023
Q4 | $68.4M | Sell |
1,088,486
-254,265
| -19% | -$16M | 1.53% | 20 |
|
|
2023
Q3 | $68.5M | Sell |
1,342,751
-271,371
| -17% | -$13.8M | 2.28% | 12 |
|
|
2023
Q2 | $80.6M | Buy |
1,614,122
+444,122
| +38% | +$22.2M | 2.33% | 12 |
|
|
2023
Q1 | $43.9M | Hold |
1,170,000
| – | – | 1.29% | 22 |
|
|
2022
Q4 | $56.1M | Buy |
+1,170,000
| New | +$56.1M | 1.58% | 20 |
|
|
2021
Q2 | – | Sell |
-850,000
| Closed | -$16.8M | – | 155 |
|
|
2021
Q1 | $16.8M | Hold |
850,000
| – | – | 0.21% | 81 |
|
|
2020
Q4 | $22.6M | Hold |
850,000
| – | – | 0.24% | 79 |
|
|
2020
Q3 | $42M | Hold |
850,000
| – | – | 0.61% | 43 |
|
|
2020
Q2 | $26.9M | Buy |
+850,000
| New | +$26.9M | 0.44% | 52 |
|